Chronic myelogenous leukemia occurring in two brothers: The opposite sides of the same coin?

Verrou, Evgenia; Tsirou, Kyriaki; Karampatzakis, Nikolaos; Triantafyllou, Theodora; Sevastoudi, Aggeliki; Grigoriadou, Georgia I; Konstantinidou, Pavlina; Panagiotidis, Panagiotis; Katodritou, Eirini

Verrou, Evgenia; Tsirou, Kyriaki; Karampatzakis, Nikolaos; Triantafyllou, Theodora; Sevastoudi, Aggeliki; Grigoriadou, Georgia I; Konstantinidou, Pavlina; Panagiotidis, Panagiotis; Katodritou, Eirini.

Afiliación

Verrou E; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
Tsirou K; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
Karampatzakis N; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
Triantafyllou T; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
Sevastoudi A; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
Grigoriadou GI; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
Konstantinidou P; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
Panagiotidis P; Μolecular Diagnostics Unit, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
Katodritou E; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.

Leuk Res Rep ; 16: 100261, 2021.

Article en En | MEDLINE | ID: mdl-34401318

Palabras clave

Familial CML; Tyrosine kinase inhibitors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Leuk Res Rep Año: 2021 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google